37
Participants
Start Date
November 30, 2009
Primary Completion Date
March 31, 2021
Study Completion Date
August 15, 2023
cisplatin
60-minute intravenous (IV) infusion of 15 mg/m\^2 on days 1, 2, 3, 15, 16, 17, 29, 30, and 31 of radiation treatment.
5-fluorouracil
Continuous IV infusion of 500 mg/m\^2/24 hrs for 5 consecutive days during weeks 1 and 4 of radiation treatment.
Mitomycin
IV bolus dose of 12 mg/m\^2 on day 1 of radiation treatment.
Three-Dimensional Conformal Radiation Therapy
Total dose to the gross bladder volume of 61.2 Gy as 34 daily fractions 5 days/week, for approximately 7 weeks.
St. Agnes Hospital Cancer Center, Baltimore
Emory Crawford Long Hospital, Atlanta
Winship Cancer Institute of Emory University, Atlanta
Barberton Citizens Hospital, Barberton
Cancer Care Center, Incorporated, Salem
Cancer Treatment Center, Wooster
Hudner Oncology Center at Saint Anne's Hospital - Fall River, Fall River
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon
Beth Israel Medical Center - Petrie Division, New York
Summa Center for Cancer Care at Akron City Hospital, Akron
Fox Chase Cancer Center - Philadelphia, Philadelphia
University of Texas Medical Branch, Galveston
Norris Cotton Cancer Center - North, Saint Johnsbury
Collaborators (1)
National Cancer Institute (NCI)
NIH
NRG Oncology
OTHER
Radiation Therapy Oncology Group
NETWORK